119 related articles for article (PubMed ID: 11401932)
1. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Lim TH; Yang HS; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
Circulation; 2001 Jun; 103(23):2784-7. PubMed ID: 11401932
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy.
Lee CW; Lee JH; Kim JJ; Park SW; Hong MK; Kim ST; Lim TH; Park SJ
J Am Coll Cardiol; 1999 Apr; 33(5):1196-202. PubMed ID: 10193716
[TBL] [Abstract][Full Text] [Related]
3. Effects of heart transplantation on cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Yang HS; Lim KH; Ahn JM; Hong MK; Park SW; Park SJ; Song MG; Kim JJ
J Heart Lung Transplant; 2006 Mar; 25(3):353-5. PubMed ID: 16507431
[TBL] [Abstract][Full Text] [Related]
4. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
5. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
6. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Ziyeh S; Thiel T; Spreer J; Klisch J; Schumacher M
Epilepsia; 2002 Sep; 43(9):1101-5. PubMed ID: 12199737
[TBL] [Abstract][Full Text] [Related]
7. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
8. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.
Brockmann K; Dechent P; Wilken B; Rusch O; Frahm J; Hanefeld F
Neurology; 2003 Mar; 60(5):819-25. PubMed ID: 12629240
[TBL] [Abstract][Full Text] [Related]
9. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cerebral metabolites with clinical outcome among patients with severe congestive heart failure.
Malloy CR
Circulation; 2001 Jun; 103(23):2771-2. PubMed ID: 11401928
[No Abstract] [Full Text] [Related]
11. 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Lam WW; Wang ZJ; Zhao H; Berry GT; Kaplan P; Gibson J; Kaplan BS; Bilaniuk LT; Hunter JV; Haselgrove JC; Zimmermann RA
Neuroradiology; 1998 May; 40(5):315-23. PubMed ID: 9638674
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
13. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
14. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
15. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Shonk TK; Moats RA; Gifford P; Michaelis T; Mandigo JC; Izumi J; Ross BD
Radiology; 1995 Apr; 195(1):65-72. PubMed ID: 7892497
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
17. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
18. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.
Videen JS; Michaelis T; Pinto P; Ross BD
J Clin Invest; 1995 Feb; 95(2):788-93. PubMed ID: 7860762
[TBL] [Abstract][Full Text] [Related]
19. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.
Michaelis T; Videen JS; Linsey MS; Ross BD
J Magn Reson Imaging; 1996; 6(2):341-7. PubMed ID: 9132100
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of linear nevus sebaceus syndrome.
Kruse B; Pouwels PJ; Christen HJ; Frahm J; Hanefeld FA
Pediatr Neurol; 1998 Feb; 18(2):176-80. PubMed ID: 9535307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
